Teva Pharmaceutical Industries Limited (TEVA)
USD 21.2
(1.53%)
USD 21.2
(1.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.36 Billion | 1.59 Billion | 798 Million | 1.21 Billion | 538 Million | 2.44 Billion |
| Net Income | -615 Million | -2.4 Billion | 456 Million | -4.09 Billion | 76 Million | -2.47 Billion |
| Depreciation & Amortization | 1.15 Billion | 1.3 Billion | 1.33 Billion | 1.55 Billion | 416 Million | 1.84 Billion |
| Deferred income taxes | -317 Million | -1.05 Billion | -120 Million | -696 Million | -333 Million | -837 Million |
| Stock-based compensation | 121 Million | 124 Million | 119 Million | 129 Million | 20 Million | 155 Million |
| Change in working capital | -72 Million | 1.25 Billion | -1.7 Billion | -2.18 Billion | -112 Million | -1.82 Billion |
| Other non-cash items | 1.09 Billion | 2.36 Billion | 714 Million | 6.51 Billion | 471 Million | 5.58 Billion |
| Investing Cash Flow | 968 Million | 656 Million | 1.52 Billion | 863 Million | 430 Million | 1.86 Billion |
| Investments in PPE | -526 Million | -548 Million | -562 Million | -578 Million | -119 Million | -651 Million |
| Acquisitions | 68 Million | 61 Million | 1.95 Billion | 67 Million | -343 Million | 1.73 Billion |
| Investment purchases | -46 Million | -1 Million | -47 Million | -55 Million | -3 Million | -119 Million |
| Sales/Maturities of investments | 1.47 Billion | 4 Million | 172 Million | 12 Million | 343 Million | 890 Million |
| Other Investing Activities | -5 Million | 1.14 Billion | 1 Million | 1.41 Billion | 552 Million | 11 Million |
| Financing Cash Flow | -1.91 Billion | -1.48 Billion | -2.17 Billion | -1.88 Billion | -241 Million | -3.35 Billion |
| Debt repayment | -4.85 Billion | -1.36 Billion | -7.84 Billion | -2.43 Billion | -2.22 Billion | -7.44 Billion |
| Dividends payments | - | - | - | - | -52 Million | -22 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.93 Billion | -118 Million | 5.66 Billion | 545 Million | 2.04 Billion | 4.11 Billion |
| Accounts receivables | 12 Million | 334 Million | -574 Million | -293 Million | -394 Million | 88 Million |
| Accounts payables | 1.58 Billion | 1.91 Billion | 764 Million | -463 Million | 643 Million | -500 Million |
| Inventory | -147 Million | -163 Million | 380 Million | 41 Million | 271 Million | 26 Million |
| Other working capital | -1.52 Billion | -828 Million | -2.27 Billion | -1.47 Billion | -632 Million | -1.43 Billion |
| Cash at beginning of period | 2.83 Billion | 2.19 Billion | 2.17 Billion | 1.97 Billion | 1.24 Billion | 963 Million |
| Cash at end of period | 3.22 Billion | 2.83 Billion | 2.19 Billion | 2.17 Billion | 1.97 Billion | 1.78 Billion |
| Capital Expenditure | -526 Million | -548 Million | -562 Million | -578 Million | -119 Million | -651 Million |
| Effect of forex changes on cash | -30 Million | -123 Million | -128 Million | 8 Million | 7 Million | -142 Million |
| Net cash flow / Change in cash | 393 Million | 636 Million | 21 Million | 202 Million | 734 Million | 819 Million |
| Free Cash Flow | 842 Million | 1.04 Billion | 236 Million | 638 Million | 419 Million | 1.79 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -845 Million | -139 Million | 433 Million | -615 Million | 88 Million | -898 Million |
| Depreciation & Amortization | 259 Million | 272 Million | 266 Million | 1.15 Billion | 283 Million | 300 Million |
| Deferred income taxes | -424 Million | -189 Million | 32 Million | -317 Million | -199 Million | -44 Million |
| Stock-based compensation | 32 Million | 28 Million | 28 Million | 121 Million | 31 Million | 30 Million |
| Change in working capital | -10 Million | -497 Million | 326 Million | -72 Million | -238 Million | 204 Million |
| Other non-cash items | 1.95 Billion | 1.26 Billion | 99 Million | 1.09 Billion | 40 Million | 732 Million |
| Investing Cash Flow | -139 Million | -215 Million | 301 Million | 968 Million | 184 Million | 302 Million |
| Investments in PPE | -97 Million | -124 Million | -119 Million | -526 Million | -149 Million | -119 Million |
| Acquisitions | 1 Million | -78.99 Million | -68 Million | 68 Million | 10 Million | 56 Million |
| Investment purchases | -43 Million | -12 Million | -2 Million | -46 Million | -38 Million | -2 Million |
| Sales/Maturities of investments | - | - | -361 Million | 1.47 Billion | -10 Million | 371 Million |
| Other Investing Activities | -42 Million | -11.99 Million | 422 Million | -5 Million | 371 Million | -4 Million |
| Financing Cash Flow | -966 Million | -87 Million | -576 Million | -1.91 Billion | -576 Million | -55 Million |
| Debt repayment | -956 Million | - | -500 Million | -4.85 Billion | -1.2 Billion | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -10 Million | -87 Million | -76 Million | 2.93 Billion | 624 Million | -55 Million |
| Accounts receivables | 317 Million | 295 Million | 421 Million | 12 Million | 362 Million | 371 Million |
| Accounts payables | - | - | 473 Million | 1.58 Billion | - | - |
| Inventory | - | - | -147 Million | -147 Million | - | - |
| Other working capital | -10 Million | -497 Million | -421 Million | -1.52 Billion | -600 Million | -167 Million |
| Cash at beginning of period | 2.99 Billion | 3.22 Billion | 2.25 Billion | 2.83 Billion | 2.67 Billion | 2.17 Billion |
| Cash at end of period | 2.25 Billion | 2.99 Billion | 3.22 Billion | 3.22 Billion | 2.25 Billion | 2.67 Billion |
| Capital Expenditure | -97 Million | -124 Million | -119 Million | -526 Million | -149 Million | -119 Million |
| Effect of forex changes on cash | -49 Million | -104 Million | 68 Million | -30 Million | -33 Million | -77 Million |
| Net cash flow / Change in cash | -733 Million | -235 Million | 977 Million | 393 Million | -420 Million | 494 Million |
| Free Cash Flow | 323 Million | 47 Million | 1.06 Billion | 842 Million | -144 Million | 205 Million |
GBIM
NDBKY
UNICHEMLAB
LHFG
600803
NIRAJ